INmune Bio, Inc. (INMB) Tops Q1 EPS by 6c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.43), $0.06 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $50 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Cooper Companies (COO) PT Lowered to $75 at Mizuho, 'remains undervalued'
• Adobe Systems (ADBE) call put ratio 1 call to 1.3 puts into quarter results